{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:08:56Z","timestamp":1790683736469,"version":"4.1.0"},"reference-count":139,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1016\/j.ecl.2007.03.008","type":"journal-article","created":{"date-parts":[[2007,6,4]],"date-time":"2007-06-04T09:07:09Z","timestamp":1180948029000},"page":"399-419","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":80,"title":["Osteoporosis in Men"],"prefix":"10.1016","volume":"36","author":[{"given":"Luigi","family":"Gennari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Bilezikian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ecl.2007.03.008_bib1","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0140-6736(02)08657-9","article-title":"Epidemiology and outcomes of osteoporotic fractures","volume":"359","author":"Cummings","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ecl.2007.03.008_bib2","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s001980050224","article-title":"Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis","volume":"10","author":"Genant","year":"1999","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.ecl.2007.03.008_bib3","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF01623184","article-title":"Hip fractures in the elderly: a worldwide projection","volume":"2","author":"Cooper","year":"1992","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.ecl.2007.03.008_bib4","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s001980070037","article-title":"Effects of body size and skeletal site on the\u00a0estimated prevalence of osteoporosis in women and men","volume":"11","author":"Melton","year":"2000","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.ecl.2007.03.008_bib5","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bone.2003.10.001","article-title":"Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study","volume":"34","author":"Schuitt","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.ecl.2007.03.008_bib6","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1359\/JBMR.050304","article-title":"Predictive value of BMD for hip and other fractures","volume":"20","author":"Johnell","year":"2005","journal-title":"J Bone Miner Res"},{"issue":"10","key":"10.1016\/j.ecl.2007.03.008_bib7","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1359\/jbmr.060708","article-title":"Osteoporotic Fractures in Men (MrOS) Research Groups; Study of Osteoporotic Fractures Research Groups. BMD and risk of hip and nonvertebral fractures in older men: a prospective study and comparison with older women","volume":"21","author":"Cummings","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ecl.2007.03.008_bib8","unstructured":"Melton LJ. Epidemiology of fractures. In: Riggs BL, Melton LJ, editors. Osteoporosis: etiology, diagnosis and management. 2nd edition. Philadelphia: Lippincott-Raven Publishers; 1995. p. 225\u201347."},{"key":"10.1016\/j.ecl.2007.03.008_bib9","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1002\/jbmr.5650070902","article-title":"How many women have osteoporosis?","volume":"7","author":"Melton","year":"1992","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ecl.2007.03.008_bib10","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s001980070064","article-title":"Long-term risk of osteoporotic fracture in Malm\u00f6","volume":"11","author":"Kanis","year":"2000","journal-title":"Osteoporos Int"},{"issue":"12","key":"10.1016\/j.ecl.2007.03.008_bib11","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1359\/jbmr.1998.13.12.1915","article-title":"Bone density and fracture risk in men","volume":"13","author":"Melton","year":"1998","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ecl.2007.03.008_bib12","first-page":"51","article-title":"Osteoporosis and men, leaflet from Osteoporosis Australia","volume":"167","year":"1997","journal-title":"Med J Aust"},{"key":"10.1016\/j.ecl.2007.03.008_bib13","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF02555245","article-title":"Secular trends in the incidence of hip fractures","volume":"41","author":"Melton","year":"1987","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.ecl.2007.03.008_bib14","doi-asserted-by":"crossref","unstructured":"Seeman E. Osteoporosis in men. Am J Med 1993;30:S22\u20138.","DOI":"10.1016\/0002-9343(93)90377-2"},{"key":"10.1016\/j.ecl.2007.03.008_bib15","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/jbmr.5650070214","article-title":"Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota 1985\u201389","volume":"7","author":"Cooper","year":"1992","journal-title":"J Bone Miner Res"},{"issue":"1S","key":"10.1016\/j.ecl.2007.03.008_bib16","first-page":"118S","article-title":"The European vertebral osteoporosis study in Siena, Italy","volume":"16","author":"Agnusdei","year":"1994","journal-title":"Bone"},{"key":"10.1016\/j.ecl.2007.03.008_bib17","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/S8756-3282(09)80004-5","article-title":"Epidemiology of osteoporosis","volume":"13","author":"Kanis","year":"1992","journal-title":"Bone"},{"key":"10.1016\/j.ecl.2007.03.008_bib18","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2106\/00004623-196244010-00009","article-title":"Epidemiology of fractures of the forearm","volume":"44","author":"Alffram","year":"1962","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.ecl.2007.03.008_bib19","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1359\/jbmr.2003.18.10.1766","article-title":"Structural and biomechanical basis of sexual dimorphism in femoral neck fragility has its origins in growth and aging","volume":"18","author":"Duan","year":"2003","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ecl.2007.03.008_bib20","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.bone.2004.11.015","article-title":"Varying contributions of growth and ageing to racial and sex differences in femoral neck structure and strength in old age","volume":"36","author":"Wang","year":"2005","journal-title":"Bone"},{"issue":"11","key":"10.1016\/j.ecl.2007.03.008_bib21","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00198-006-0160-8","article-title":"Bone fragility in men\u2014where are we?","volume":"17","author":"Seeman","year":"2006","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.ecl.2007.03.008_bib22","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1359\/jbmr.040916","article-title":"A population-based study of age and sex differences in bone volumetric density, size, geometry and structure at different skeletal sites","volume":"19","author":"Riggs","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ecl.2007.03.008_bib23","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00223-001-1047-5","article-title":"Histomorphometric approach of bone loss in men","volume":"69","author":"Chavassieux","year":"2001","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.ecl.2007.03.008_bib24","first-page":"2792","article-title":"Editorial: Idiopathic osteoporosis\u2014is the osteoblast to blame?","volume":"82","author":"Khosla","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2007.03.008_bib25","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s00223-005-0158-9","article-title":"Osteoblast dysfunction in male idiopathic osteoporosis","volume":"78","author":"Pernow","year":"2006","journal-title":"Calcif Tissue Int"},{"issue":"2","key":"10.1016\/j.ecl.2007.03.008_bib26","first-page":"77","article-title":"Idiopathic osteoporosis: a heterogeneous entity","volume":"149","author":"Heshmati","year":"1998","journal-title":"Ann Med Interne (Paris)"},{"key":"10.1016\/j.ecl.2007.03.008_bib27","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/archinte.1982.00340200053014","article-title":"Osteoporosis in young men","volume":"142","author":"Perry","year":"1982","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ecl.2007.03.008_bib28","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1365-2362.1992.tb01503.x","article-title":"Bone mass with biochemical parameters of bone metabolism in men with spinal osteoporosis","volume":"22","author":"Resch","year":"1992","journal-title":"J Clin Invest"},{"issue":"10","key":"10.1016\/j.ecl.2007.03.008_bib29","first-page":"3431","article-title":"Osteoporosis in men","volume":"84","author":"Bilezikian","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2007.03.008_bib30","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1210\/edrv-16-1-87","article-title":"Osteoporosis in men","volume":"16","author":"Orwoll","year":"1995","journal-title":"Endocr Rev"},{"issue":"Suppl 5A","key":"10.1016\/j.ecl.2007.03.008_bib31","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0002-9343(93)90377-2","article-title":"Osteoporosis in men: epidemiology, pathophysiology, and treatment possibilities","volume":"95","author":"Seeman","year":"1993","journal-title":"Am J Med"},{"issue":"12","key":"10.1016\/j.ecl.2007.03.008_bib32","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1007\/s00198-005-1866-8","article-title":"Mr. OS Research Group. Factors associated with the lumbar spine and proximal femur bone mineral density in older men","volume":"16","author":"Cauley","year":"2005","journal-title":"Osteoporos Int"},{"issue":"2","key":"10.1016\/j.ecl.2007.03.008_bib33","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00198-005-2019-9","article-title":"The determinants of bone mineral density in Chinese men\u2014results from Mr. Os (Hong Kong), the first cohort study on osteoporosis in Asian men","volume":"17","author":"Lau","year":"2006","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.ecl.2007.03.008_bib34","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/0002-9343(83)90878-1","article-title":"Risk factors for spinal osteoporosis in men","volume":"75","author":"Seeman","year":"1983","journal-title":"Am J Med"},{"key":"10.1016\/j.ecl.2007.03.008_bib35","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1359\/jbmr.1997.12.11.1761","article-title":"Prevalence of low femoral bone density in older US adults from NHANES III","volume":"12","author":"Looker","year":"1997","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ecl.2007.03.008_bib36","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1172\/JCI107476","article-title":"Genetic factors in determining bone mass","volume":"52","author":"Smith","year":"1973","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.ecl.2007.03.008_bib37","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s00223-001-1049-3","article-title":"Genetics of male osteoporosis","volume":"69","author":"Gennari","year":"2001","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.ecl.2007.03.008_bib38","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1210\/edrv.20.6.0384","article-title":"Genetics of osteoporosis","volume":"20","author":"Eisman","year":"1999","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ecl.2007.03.008_bib39","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1359\/jbmr.1998.13.12.1909","article-title":"Bone mass in middle-aged osteoporotic men and their relatives: familial effect","volume":"13","author":"Cohen-Solal","year":"1998","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ecl.2007.03.008_bib40","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/jbmr.5650090602","article-title":"Family history of osteoporosis and bone mineral density at the axial skeleton: the Rancho-Bernardo Study","volume":"9","author":"Soroko","year":"1994","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ecl.2007.03.008_bib41","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S8756-3282(96)00331-6","article-title":"European Vertebral Osteoporosis Study Group. The influence of family history of hip fracture on the risk of vertebral deformity in men and women: the European Vertebral Osteoporosis Study","volume":"20","author":"Diaz","year":"1997","journal-title":"Bone"},{"issue":"6","key":"10.1016\/j.ecl.2007.03.008_bib42","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1210\/jc.2003-031342","article-title":"A polymorphic CYP19 TTTA repeat influences aromatase activity and estrogen levels in elderly men: effects on bone metabolism","volume":"89","author":"Gennari","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.ecl.2007.03.008_bib43","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1210\/jc.2002-021691","article-title":"Bioavailable estradiol and aromatase gene polymorphism are determinants of bone mineral density changes in men over 70 years of age","volume":"88","author":"Van Pottelbergh","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ecl.2007.03.008_bib44","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.bone.2005.06.017","article-title":"LRP5 gene polymorphisms and idiopathic osteoporosis in men","volume":"37","author":"Ferrari","year":"2005","journal-title":"Bone"},{"key":"10.1016\/j.ecl.2007.03.008_bib45","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1210\/jcem.83.7.4964","article-title":"An association between serum IGF-1 and a simple sequence repeat in the IGF-1 gene: implications for genetic studies of bone mineral density","volume":"83","author":"Rosen","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ecl.2007.03.008_bib46","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1210\/edrv.23.3.0465","article-title":"Sex steroids and the construction and conservation of the adult skeleton","volume":"23","author":"Riggs","year":"2002","journal-title":"Endocr Rev"},{"issue":"2","key":"10.1016\/j.ecl.2007.03.008_bib47","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1210\/jcem.86.2.7219","article-title":"Longitudinal effects of aging on serum total and free testosterone levels in healthy men","volume":"86","author":"Harman","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.ecl.2007.03.008_bib48","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1210\/jcem.86.8.7736","article-title":"Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men","volume":"86","author":"Khosla","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.ecl.2007.03.008_bib49","doi-asserted-by":"crossref","first-page":"5327","DOI":"10.1210\/jc.2003-030736","article-title":"Longitudinal association between sex hormone levels, bone loss, and bone turnover in elderly men","volume":"88","author":"Gennari","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2007.03.008_bib50","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1126\/science.278.5337.419","article-title":"The endocrinology of aging","volume":"278","author":"Lamberts","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.ecl.2007.03.008_bib51","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1210\/jcem-73-5-1016","article-title":"Age, disease and changing sex hormone levels in middle-aged men: results of the Massachusetts male aging study","volume":"73","author":"Gray","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2007.03.008_bib52","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0950-351X(97)80302-3","article-title":"Declining gonadal function in elderly men","volume":"11","author":"Kaufman","year":"1997","journal-title":"Baillieres Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ecl.2007.03.008_bib53","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1210\/jc.2005-1830","article-title":"Testosterone and estradiol among older men","volume":"91","author":"Orwoll","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.ecl.2007.03.008_bib54","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1172\/JCI119701","article-title":"Sex steroids and bone mass in older men: positive associations with serum estrogens and negative associations with androgens","volume":"100","author":"Slemenda","year":"1997","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.ecl.2007.03.008_bib55","first-page":"192","article-title":"Bioavailable estradiol may be an important determinant of osteoporosis in men. The MINOS Study","volume":"86","author":"Szulc","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.ecl.2007.03.008_bib56","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1359\/jbmr.1997.12.11.1833","article-title":"Endogenous sex steroids and bone mineral density in older women and men: the Rancho Bernardo Study","volume":"12","author":"Greendale","year":"1997","journal-title":"J Bone Miner Res"},{"issue":"7","key":"10.1016\/j.ecl.2007.03.008_bib57","first-page":"2266","article-title":"Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen","volume":"83","author":"Khosla","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ecl.2007.03.008_bib58","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1046\/j.1365-2265.1998.00631.x","article-title":"Serum estradiol and oestrogen-receptor gene polymorphism are associated with bone mineral density independently of serum testosterone in normal males","volume":"49","author":"Ongphiphadhanakul","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"12","key":"10.1016\/j.ecl.2007.03.008_bib59","doi-asserted-by":"crossref","first-page":"951","DOI":"10.7326\/0003-4819-133-12-200012190-00010","article-title":"Association of hypogonadism and estradiol levels with bone mineral density in elderly men from the Framingham study","volume":"133","author":"Amin","year":"2000","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.ecl.2007.03.008_bib60","first-page":"219","article-title":"Low levels of estradiol are associated with vertebral fractures in older men, but not women: the Rancho Bernardo Study","volume":"85","author":"Barrett-Connor","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ecl.2007.03.008_bib61","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1210\/jcem.87.4.8417","article-title":"Clinical review 144: estrogen and the male skeleton","volume":"87","author":"Khosla","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ecl.2007.03.008_bib62","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1359\/JBMR.041228","article-title":"Relationship of volumetric BMD and structural parameters at different skeletal sites to sex steroid levels in men","volume":"20","author":"Khosla","year":"2005","journal-title":"J Bone Miner Res"},{"issue":"12","key":"10.1016\/j.ecl.2007.03.008_bib63","doi-asserted-by":"crossref","first-page":"5898","DOI":"10.1210\/jc.2004-1717","article-title":"Aromatase activity and bone homeostasis in men","volume":"89","author":"Gennari","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ecl.2007.03.008_bib64","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1210\/endo.131.4.1396346","article-title":"Estrogen synthesis by osteoblast cell lines","volume":"131","author":"Purohit","year":"1992","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.ecl.2007.03.008_bib65","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF00308318","article-title":"Aromatase activity in human osteoblast-like osteosarcoma cell","volume":"52","author":"Tanaka","year":"1993","journal-title":"Calcif Tissue Int"},{"issue":"9","key":"10.1016\/j.ecl.2007.03.008_bib66","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1359\/jbmr.1997.12.9.1416","article-title":"Aromatase in human bone tissue","volume":"12","author":"Sasano","year":"1997","journal-title":"J Bone Miner Res"},{"issue":"1","key":"10.1016\/j.ecl.2007.03.008_bib67","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-2265.1995.tb01890.x","article-title":"Oestrogen formation from androstenedione in human bone","volume":"43","author":"Schweikert","year":"1995","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"11","key":"10.1016\/j.ecl.2007.03.008_bib68","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.1210\/endo.142.11.8547","article-title":"Minireview: aromatase and the regulation of estrogen biosynthesis\u2014some new perspectives","volume":"142","author":"Simpson","year":"2001","journal-title":"Endocrinology"},{"issue":"5\u20136","key":"10.1016\/j.ecl.2007.03.008_bib69","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0039-128X(98)00007-5","article-title":"DHEA and the intracrine formation of androgens and estrogens in peripheral target tissue: its role during aging","volume":"63","author":"Labrie","year":"1998","journal-title":"Steroids"},{"issue":"4","key":"10.1016\/j.ecl.2007.03.008_bib70","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1210\/jc.2004-1805","article-title":"Osteoporotic Fractures in Men Study Research Group. Voluntary weight reduction in older men increases hip bone loss: the osteoporotic fractures in men study","volume":"90","author":"Ensrud","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.ecl.2007.03.008_bib71","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1007\/s00198-006-0088-z","article-title":"Osteoporotic Fractures in Men MrOS Study Research Group. Endogenous sex steroids, weight change and rates of hip bone loss in older men: the MrOS study","volume":"17","author":"Ensrud","year":"2006","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.ecl.2007.03.008_bib72","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3181\/00379727-206-43726","article-title":"Insulin-like growth factors and bone: the osteoporosis connection","volume":"206","author":"Rosen","year":"1994","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.ecl.2007.03.008_bib73","first-page":"2534","article-title":"Relationship between circulating insulin-like growth factor components and sex hormones in a population-based sample of 50- to 80-year-old men and women","volume":"81","author":"Pfeilshifter","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2007.03.008_bib74","first-page":"1283","article-title":"Differential effects of insulin-like growth factor I on the production of plasma steroid-binding globulins by human hepatoblastoma-derived (HepG2) cells","volume":"80","author":"Crave","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2007.03.008_bib75","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S8756-3282(98)00135-5","article-title":"Histomorphometric, physical, and mechanical effects of spaceflight and insulin-like growth factor-I on rat long bones","volume":"23","author":"Bateman","year":"1998","journal-title":"Bone"},{"key":"10.1016\/j.ecl.2007.03.008_bib76","first-page":"2799","article-title":"Insulin-like growth factor-1 men with idiopathic osteoporosis","volume":"82","author":"Kurland","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2007.03.008_bib77","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1365-2796.1992.tb00550.x","article-title":"Low plasma levels of insulin-like growth factor 1 (IGF-1) in male patients with idiopathic osteoporosis","volume":"232","author":"Ljunghall","year":"1992","journal-title":"J Intern Med"},{"key":"10.1016\/j.ecl.2007.03.008_bib78","first-page":"2576","article-title":"Normal growth hormone secretory reserve in men with idiopathic osteoporosis and reduced circulating levels of insulin-like growth factor-1","volume":"83","author":"Kurland","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2007.03.008_bib79","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1359\/JBMR.050916","article-title":"Effects of sex and age on bone microstructure at the ultradistal radius: a population-based noninvasive in vivo assessment","volume":"21","author":"Khosla","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ecl.2007.03.008_bib80","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1210\/jc.2005-2065","article-title":"Hormonal and biochemical determinants of trabecular microstructure at the ultradistal radius in women and men","volume":"91","author":"Khosla","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.ecl.2007.03.008_bib81","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1210\/jc.2004-0602","article-title":"Estrogen are essential for male pubertal periosteal expansion","volume":"89","author":"Boullion","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2007.03.008_bib82","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1210\/rp.57.1.385","article-title":"Sex steroids and bone","volume":"57","author":"Manolagas","year":"2002","journal-title":"Recent Prog Horm Res"},{"issue":"5594","key":"10.1016\/j.ecl.2007.03.008_bib83","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1126\/science.1074935","article-title":"Reversal of bone loss in mice by nongenotropic signaling of sex steroids","volume":"298","author":"Kousteni","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.ecl.2007.03.008_bib84","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1359\/jbmr.2000.15.10.1867","article-title":"Assessing bone density in men","volume":"15","author":"Orwoll","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ecl.2007.03.008_bib85","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1210\/jc.2004-0124","article-title":"International Society for Clinical Densitometry. Official positions of the international society for clinical densitometry","volume":"89","author":"Lewiecki","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2007.03.008_bib86","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1359\/jbmr.1998.13.9.1431","article-title":"Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial","volume":"13","author":"Greenspan","year":"1998","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ecl.2007.03.008_bib87","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S8756-3282(98)00183-5","article-title":"Biochemical markers can predict the response in bone mass during alendronate treatment in early postmenopausal women","volume":"24","author":"Ravn","year":"1999","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.ecl.2007.03.008_bib88","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bone.2004.09.004","article-title":"Biochemical markers of bone formation reflect endosteal bone loss in elderly men-MINOS study","volume":"36","author":"Szulc","year":"2005","journal-title":"Bone"},{"key":"10.1016\/j.ecl.2007.03.008_bib89","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1001\/archinte.162.19.2217","article-title":"Undertreatment of osteoporosis in men with hip fracture","volume":"162","author":"Kiebzak","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ecl.2007.03.008_bib90","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1001\/archinte.163.18.2165","article-title":"Bone mineral density measurement and treatment for osteoporosis in older individuals with fractures: A gap in evidence-based practice guideline","volume":"163","author":"Feldstein","year":"2003","journal-title":"Arch Intern Med"},{"issue":"8","key":"10.1016\/j.ecl.2007.03.008_bib91","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s00198-005-1950-0","article-title":"The near absence of osteoporosis treatment in older men with fractures","volume":"16","author":"Feldstein","year":"2005","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.ecl.2007.03.008_bib92","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1001\/jama.1994.03520240070044","article-title":"Panel Members. Optimal calcium intake: statement of the consensus development panel on optimal calcium intake","volume":"272","author":"Bilezikian","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.ecl.2007.03.008_bib93","series-title":"Dietary reference intakes","author":"Food and Nutrition Board, Institute of Medicine, National Research Council","year":"1998"},{"key":"10.1016\/j.ecl.2007.03.008_bib94","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s00223-004-0288-5","article-title":"Treatment of osteoporosis in men","volume":"75","author":"Orwoll","year":"2004","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.ecl.2007.03.008_bib95","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1056\/NEJM200008313430902","article-title":"Alendronate for the treatment of osteoporosis in men","volume":"43","author":"Orwoll","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ecl.2007.03.008_bib96","doi-asserted-by":"crossref","first-page":"5252","DOI":"10.1210\/jcem.86.11.7988","article-title":"Alendronate treatment of established primary osteoporosis in men: results of a 2-year prospective study","volume":"86","author":"Ringe","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2007.03.008_bib97","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1053\/meta.2001.24925","article-title":"Effect of alendronate on bone mineral density in male idiopathic osteoporosis","volume":"50","author":"Weber","year":"2001","journal-title":"Metabolism"},{"key":"10.1016\/j.ecl.2007.03.008_bib98","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00223-002-1085-7","article-title":"Alendronate treatment in men with primary osteoporosis: a three-year longitudinal study","volume":"73","author":"Gonnelli","year":"2003","journal-title":"Calcif Tissue Int"},{"issue":"2","key":"10.1016\/j.ecl.2007.03.008_bib99","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s00296-003-0388-y","article-title":"Alendronate treatment of established primary osteoporosis in men: 3-year results of a prospective, comparative, two-arm study","volume":"24","author":"Ringe","year":"2004","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.ecl.2007.03.008_bib100","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/PL00004182","article-title":"Effects of alendronate on bone density in men with primary and secondary osteoporosis","volume":"11","author":"Ho","year":"2000","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.ecl.2007.03.008_bib101","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s10067-006-0252-z","article-title":"Comparison of the effect of alendronate on lumbar bone mineral density and bone turnover in men and postmenopausal women with osteoporosis","volume":"26","author":"Iwamoto","year":"2006","journal-title":"Clin Rheumatol"},{"issue":"6","key":"10.1016\/j.ecl.2007.03.008_bib102","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.bone.2003.12.028","article-title":"Cost effectiveness of alendronate for the treatment of male osteoporosis in Sweden","volume":"4","author":"Borgstrom","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.ecl.2007.03.008_bib103","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1471-2474-6-39","article-title":"Does alendronate reduce the risk of fracture in men? A meta-analysis incorporating prior knowledge of anti-fracture efficacy in women","volume":"6","author":"Sawka","year":"2005","journal-title":"BMC Musculoskelet Disord"},{"issue":"4","key":"10.1016\/j.ecl.2007.03.008_bib104","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1210\/er.2001-2002","article-title":"Meta-analyses of therapies for postmenopausal osteoporosis. II. Meta-analysis of alendronate for the treatment of postmenopausal women","volume":"23","author":"Cranney","year":"2002","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ecl.2007.03.008_bib105","unstructured":"Miller P, Orwoll E, MacIntyre B, et\u00a0al. Treatment with alendronate 70 mg once weekly for 12 months increases BMD and decreases biochemical markers of bone turnover in men with osteoporosis. Presented at the Second International Conference on Osteoporosis in Men. Genoa (Italy), October 4, 2003."},{"key":"10.1016\/j.ecl.2007.03.008_bib106","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.4065\/77.10.1044","article-title":"Tolerability of once-weekly alendronate in patients with osteoporosis: a randomized, double-blind, placebocontrolled study","volume":"77","author":"Greenspan","year":"2002","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"10.1016\/j.ecl.2007.03.008_bib107","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00296-005-0004-4","article-title":"Efficacy of risedronate in men with primary and secondary osteoporosis: results of a 1-year study","volume":"26","author":"Ringe","year":"2006","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.ecl.2007.03.008_bib108","doi-asserted-by":"crossref","unstructured":"de Nijs RN, Jacobs JW, Lems WF, et\u00a0al. Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis. N Engl J Med 2006;355(7):675\u201384.","DOI":"10.1056\/NEJMoa053569"},{"issue":"2","key":"10.1016\/j.ecl.2007.03.008_bib109","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ghir.2006.02.004","article-title":"Effect of alendronate on bone mineral density in adult patients with Laron syndrome (primary growth hormone insensitivity)","volume":"16","author":"Eshed","year":"2006","journal-title":"Growth Horm IGF Res"},{"issue":"12","key":"10.1016\/j.ecl.2007.03.008_bib110","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1007\/s00198-005-1879-3","article-title":"Alendronate for osteoporosis in men with androgen-repleted hypogonadism","volume":"16","author":"Shimon","year":"2005","journal-title":"Osteoporos Int"},{"issue":"3","key":"10.1016\/j.ecl.2007.03.008_bib111","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1191\/1479972304cd025oa","article-title":"Randomized controlled trial of alendronate in airways disease and low bone mineral density","volume":"1","author":"Smith","year":"2004","journal-title":"Chron Respir Dis"},{"issue":"8","key":"10.1016\/j.ecl.2007.03.008_bib112","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/lt.20466","article-title":"Alendronate in combination with calcium and vitamin D prevents bone loss after orthotopic liver transplantation: a prospective single-center study","volume":"11","author":"Millonig","year":"2005","journal-title":"Liver Transpl"},{"issue":"8","key":"10.1016\/j.ecl.2007.03.008_bib113","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1056\/NEJMoa035617","article-title":"Alendronate versus calcitriol for the prevention of bone loss after cardiac transplantation","volume":"350","author":"Shane","year":"2004","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ecl.2007.03.008_bib114","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0305-7372(03)00076-8","article-title":"Management of treatment-related osteoporosis in men with prostate cancer","volume":"29","author":"Smith","year":"2003","journal-title":"Cancer Treat Rev"},{"issue":"15","key":"10.1016\/j.ecl.2007.03.008_bib115","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1001\/archinte.165.15.1743","article-title":"Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke","volume":"165","author":"Sato","year":"2005","journal-title":"Arch Intern Med"},{"issue":"2\u20133","key":"10.1016\/j.ecl.2007.03.008_bib116","first-page":"33","article-title":"Skeletal benefit after one year of risedronate therapy in patients with rheumatoid arthritis and glucocorticoid-induced osteoporosis: a prospective study","volume":"24","author":"Lange","year":"2004","journal-title":"Int J Clin Pharmacol Res"},{"issue":"4","key":"10.1016\/j.ecl.2007.03.008_bib117","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s00223-001-1060-8","article-title":"Risedronate increases bone density and reduces vertebral fracture risk within one year in men on corticosteroid therapy","volume":"69","author":"Reid","year":"2001","journal-title":"Calcif Tissue Int"},{"issue":"6","key":"10.1016\/j.ecl.2007.03.008_bib118","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1359\/jbmr.2000.15.6.1006","article-title":"Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: a randomized trial. European Corticosteroid-Induced Osteoporosis Treatment Study","volume":"15","author":"Reid","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ecl.2007.03.008_bib119","series-title":"Physicians' desk reference: PDR","year":"2003"},{"issue":"9","key":"10.1016\/j.ecl.2007.03.008_bib120","first-page":"3069","article-title":"Parathyroid hormone as a therapy for idiopathic osteoporosis in men: effects on bone mineral density and bone markers","volume":"85","author":"Kurland","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2007.03.008_bib121","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1359\/jbmr.2003.18.1.9","article-title":"The effect of teriparatide [human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosis","volume":"18","author":"Orwoll","year":"2003","journal-title":"J Bone Miner Res"},{"issue":"3","key":"10.1016\/j.ecl.2007.03.008_bib122","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1210\/jc.2002-021988","article-title":"Effects of intermittent parathyroid hormone administration on bone mineralization density in iliac crest biopsies from patients with osteoporosis: a paired study before and after treatment","volume":"88","author":"Misof","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ecl.2007.03.008_bib123","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s00198-004-1713-3","article-title":"Teriparatide effects on vertebral fractures and bone mineral density in men with osteoporosis: treatment and discontinuation of therapy","volume":"16","author":"Kaufman","year":"2005","journal-title":"Osteoporos Int"},{"issue":"4","key":"10.1016\/j.ecl.2007.03.008_bib124","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s00223-001-1041-y","article-title":"Therapy of male osteoporosis with parathyroid hormone","volume":"69","author":"Bilezikian","year":"2001","journal-title":"Calcif Tissue Int"},{"issue":"5","key":"10.1016\/j.ecl.2007.03.008_bib125","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1210\/er.2004-0006","article-title":"Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use","volume":"26","author":"Hodsman","year":"2005","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ecl.2007.03.008_bib126","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJMoa035725","article-title":"The effects of parathyroid hormone, alendronate, or both in men with osteoporosis","volume":"349","author":"Finkelstein","year":"2003","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.ecl.2007.03.008_bib127","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1007\/s00198-004-1636-z","article-title":"The importance of bisphosphonate therapy in maintaining bone mass in men after therapy with teriparatide [human parathyroid hormone(1-34)]","volume":"15","author":"Kurland","year":"2004","journal-title":"Osteoporos Int"},{"issue":"1","key":"10.1016\/j.ecl.2007.03.008_bib128","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11914-006-0009-2","article-title":"Combination\/sequential therapies for anabolic and antiresorptive skeletal agents for osteoporosis","volume":"4","author":"Bilezikian","year":"2006","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.ecl.2007.03.008_bib129","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1210\/jcem.82.8.4163","article-title":"Long-term effect of testosterone therapy on bone mineral density in hypogonadal men","volume":"82","author":"Behre","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.ecl.2007.03.008_bib130","first-page":"2670","article-title":"Effects of testosterone replacement in hypogonadal men","volume":"85","author":"Snyder","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"16","key":"10.1016\/j.ecl.2007.03.008_bib131","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1056\/NEJMoa054629","article-title":"DHEA in elderly women and DHEA or testosterone in elderly men","volume":"355","author":"Nair","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ecl.2007.03.008_bib132","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1056\/NEJMoa010845","article-title":"Pamidronate to prevent bone loss during androgen deprivation therapy for prostate cancer","volume":"345","author":"Smith","year":"2001","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ecl.2007.03.008_bib133","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1210\/jc.2006-0036","article-title":"Testosterone use in men and its effects on bone health. A systematic review and meta-analysis of randomized placebo-controlled trials","volume":"91","author":"Tracz","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ecl.2007.03.008_bib134","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1359\/jbmr.1997.12.3.472","article-title":"Androgen supplementation in eugonadal men with osteoporosis: effects of six months' treatment on markers of bone formation and resorption","volume":"12","author":"Anderson","year":"1997","journal-title":"J Bone Miner Res"},{"issue":"18","key":"10.1016\/j.ecl.2007.03.008_bib135","first-page":"3649","article-title":"Raloxifene, a selective estrogen receptor modulator, induces apoptosis in androgen-responsive human prostate cancer cell line LNCaP through an androgen-independent pathway","volume":"62","author":"Kim","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.ecl.2007.03.008_bib136","article-title":"Clomiphene or tamoxifen for idiopathic oligo\/asthenospermia","volume":"2","author":"Vandekerckhove","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"10.1016\/j.ecl.2007.03.008_bib137","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1359\/jbmr.2001.16.11.2118","article-title":"Effects of raloxifene, a selective estrogen receptor modulator, on bone turnover markers and serum sex steroid and lipid levels in elderly men","volume":"16","author":"Doran","year":"2001","journal-title":"J Bone Miner Res"},{"issue":"9","key":"10.1016\/j.ecl.2007.03.008_bib138","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1359\/JBMR.040503","article-title":"Raloxifene treatment is associated with increased serum estradiol and decreased bone remodeling in healthy middle-aged men with low sex hormone levels","volume":"19","author":"Uebelhart","year":"2004","journal-title":"J Bone Miner Res"},{"issue":"4","key":"10.1016\/j.ecl.2007.03.008_bib139","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1530\/eje.0.1500539","article-title":"Effects of raloxifene on gonadotrophins, sex hormones, bone turnover and lipids in healthy elderly men","volume":"150","author":"Duschek","year":"2004","journal-title":"Eur J Endocrinol"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852907000254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852907000254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:29:54Z","timestamp":1760174994000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889852907000254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":139,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S0889852907000254"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2007.03.008","relation":{},"ISSN":["0889-8529"],"issn-type":[{"value":"0889-8529","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Osteoporosis in Men","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2007.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}